Advice
Discontinuation of docetaxel (Taxotere)
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.
Medicine details
- Medicine name:
- docetaxel (Taxotere)
- SMC ID:
- 481/08
- Indication:
- In combination with cisplatin and 5-fluorouracil (5-FU) is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck
- Pharmaceutical company
- Sanofi-Aventis
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Status
- Withdrawn
- Date advice published
- 07 July 2008
Additional notes
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.